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404-5 Vascular Endothelial Growth Factor (VEGF) Plays a 
Central Role in the Development of Diabetic 
Cardiomyopathy and Gene Transfer of VEGF Improves 
Heart Failure in Long-Standing Streptozotocin-Induced 
Diabetic Rat
Young-Sup Yoon, Shigeki Uchida, Jong-Seon Park, Cynthia Curry, Jeffrey M. Isner, 
Douglas W. Losordo, St. Eliazabeth's Medical Center, Tufts University School of 
Medicine, Boston, MA
Background: Diabetic cardiomyopathy (DCM), which is characterized by interstitial fibro-
sis and microvascular pathology, progressively leads to heart failure (HF). Using the
streptozotocin-induced diabetic rat model, we evaluated the natural course of DCM over
a period of one year and tested whether VEGF gene transfer could improve diabetic HF.
Methods and Results: Diastolic dysfunction developed in the early phases and pro-
gressed in all rats. Systolic dysfunction developed later and became significant in 24% of
the rats. Downregulation of myocardial VEGF expression was detected early in the
course of DCM, followed by increased apoptosis of endothelial cells (ECs), decreased
numbers of circulating endothelial progenitor cells (EPCs), and finally by decreased cap-
illary density and impaired myocardial perfusion. Ultimately, apoptosis and necrosis of
cardiomyocytes (CMCs) ensued along with fibrosis. Based on this observed sequence of
events, we evaluated a strategy of angiogenic gene therapy (GT) via direct intramyocar-
dial injection of plasmid DNA encoding VEGF(phVEGF165). Rats were randomized to
receive phVEGF165, LacZ plasmid or sham operation (n =14, each group). Only the
VEGF group showed increased capillary density and decreased EC and CMC apoptosis.
Bone marrow (BM) transplantation studies documented evidence for in situ differentiation
of BM derived EPCs into ECs in the VEGF group. These anatomic findings were accom-
panied by significant improvement in cardiac function in the VEGF group alone.
Conclusion: Here, we first demonstrate that down-regulation of VEGF plays a central
role in the pathogenesis of DCM and that replenishment of VEGF, using a direct myocar-
dial GT approach, can improve HF by augmenting neovascularization through angiogen-
esis and vasculogenesis and by reestablishing VEGF homeostasis in the myocardium.
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406-1 Hypoxia Regulatable Aav-2 Vector Protects Against 
Cardiac Ischemia/Reperfusion Injury
Alok S. Pachori, Luis G. Melo, Lunan Zhang, Richard E. Pratt, Victor J. Dzau, Brigham & 
Women's Hospital, Boston, MA, University of Saskatoon, Saskatchwaan, SK, Canada
Purpose: We have previously demonstrated that constitutive overexpression of heme-
oxygenase 1 protects against myocardial injury. The purpose of this study is to test the
efficacy of a hypoxia inducible vector encoding heme oxygenase 1, for protection against
myocardial ischemia and reperfusion injury by determining the inducibility of the vector
during ischemia and protection against ischemia and reperfusion injury.
Methods: Eight week old male Sprague-Dawley (SD) rats were divided into two groups
(n=15-16/group) and injected with either AAV-4HRE-mSV40-HO-1 OR AAV-4HRE-
mSV40-LacZ (4 X 1011 pfu/ml). Four weeks after injection, animals from both groups
were randomized and subjected to either sham surgery or surgery consisting of a 1 hour
ischemia followed by reperfusion for 6, 12 and 24 hours. Following reperfusion, tissues
were harvested and used for protein and RNA isolation and TTC staining for determina-
tion of infarct size. Separate group of animals were used for echocardiographic analysis
of cardiac function following I/R injury.
Results: Our results indicate that compared to baseline, ischemia/reperfusion injury
resulted in a significant increase in HO-1 protein and activity levels in HO-1 transduced
animals. More importantly, there was a significant decrease in the infarct size in HO-1
treated animals versus the control group (31.0 ± 5.58 vs. 12.1 ± 2.15, p<.01) as well as
complete improvement in cardiac function parameters such as ejection fraction, septal
and posterior wall thickness and LV volume and area, one month after injury, as deter-
mined by echocardiographic analyses.
Conclusion: In this study we have demonstrated that expression of exogenous hHO-1
can be regulated by hypoxia developed during global ischemia. The data indicate that
overexpression of hHO-1 during ischemia and early reperfusion has a marked protective
effect on the myocardium. This is the first evidence of the therapeutic efficacy of inducible
expression and provides proof-of-concept for the feasibility of this approach for protection
against ischemia/reperfusion injury. 
11:15 a.m.
406-2 Stem Cell Factor Plays a Critical Role in Neointimal 
Formation by Bone Marrow Derived Progenitor Cells
Subodh Verma, Chao-Hung Wang, William Stanford, Richard D. Weisel, University of 
Toronto, Toronto, Canada
We hypothesized that stem cell factor (SCF) is a critical mediator of restenosis facilitating
mobilization, homing & transdifferentiation of progenitors. Femoral injury was induced in
wildtype, WBB6F1 (W/WV) (c-kit deficient) & WCB6F1 (Sl/Sld, Steel-Dickie) (mSCF defi-
cient) mice & neointimal formation, SCF, c-kit, SMA & MMP-9 quantified. Progenitor cell
mobilization was evaluated by circulating SCF levels & CD34+ cells. Vascular injury fol-
lowing BM transplantation using donor cells expressing eYFP (BMTYfp→Wild) was per-
formed. The effects of SCF & SMCs on Lin- BM cell adhesion to fibronectin was studied
in addition to coculture of eYFP+ Lin- BM cells with activated SMC. The effects of PDGF
& A-II on SCF expression following vascular injury were evaluated, as were the effects of
long-term ACEI. W/Wv & Steel-Dickie mice exhibited marked attenuation in neointimal
formation at day 14 & 28 (P<0.001) In wild-type mice vascular injury resulted in the eleva-
tion of sSCF compared to Steel-Dickie mice & induced an increase in circulating CD34+
progenitors (P<0.01). An increase in SCF, proMMP-9 & MMP-9 expression in the adven-
titia occurred within the first week following vascular injury. BMTYfp→Wild indicated the
presence of c-kit positive cells within the medial layer expressing SMA. SCF induced a
marked increase in adhesion of BM cells to fibronectin suggesting a direct role of SCF in
progenitor recruitment (P<0.001). Activated rat SMCs increased the adhesion of BM cells
& coculture of eYFP Lin- BM cells with SMC showed clusters of cells expressing both
eYFP & SMA, suggesting that SMC activation, marked by SCF expression, is required for
progenitor differentiation. PDGF & A-II upregulated SMCc SCF expression in a dose
dependent fashion, & ACEI (BMTYfp→Wild) suppressed the number of BM derived neoint-
imal cells(P<0.01). In conclusion, vascular injury upregulates local mSCF expression &
activates MMP-9, facilitating the shedding of sSCF with resultant mobilization and hom-
ing of BM progenitors to sites of vascular injury. In-vivo deficiency of SCF or its receptor,
c-kit is associated with reduced neointimal formation. Targeting SCF may serve as a
novel therapeutic strategy for restenosis.
11:30 a.m.
406-3 Protecting Ischemic Hearts With a Hypoxia-Sensitive 
Heme Oxygenase-1 Plasmid System
Yao Liang Tang, Yi Tang, Y. Clare Zhang, Keping Qian, M. Ian Phillips, All Children 
Hospital, Children Research Institute, St. Petersburg, FL, Stanford University, Stanford, 
CA
Background: Although human heme oxygenase-1(hHO-1) could provide a useful
approach for cellular protection in the ischemic heart, constitutive over-expression of
hHO-1 may lead to unwanted side effects. We designed a hypoxia-regulated hHO-1 gene
therapy system named vigilant hHO-1 plasmid system, which is based on an oxygen
dependent degradation domain (ODD) from the hypoxia inducible factor-1-alpha (HIF-1α)
that can sense ischemia and switch on hHO-1 gene in the heart.
Methods and Results: In in vitro experiment, HEK293 cells were transfected with vigi-
lant hHO-1 plasmid, it produced a robust hHO-1 induction upon exposure to low oxygen.
In a mouse model for myocardial infarction, the vigilant hHO-1 plasmids turned on hHO-1
genes specifically to ischemic myocardium. At 10 days after gene transfer, Masson
trichrome staining showed significantly fewer fibrotic aeas in vigilant hHO-1 plasmids
treated mice compared with saline control (43.0±4.8% vs 62.5±3.3%, P<0.01), the reduc-
tion of interstitial fibrosis is accompanied by an increase in myocardial hHO-1 expression
in peri-infarct border areas, concomitant with reduced apoptosis in the ischemic myocar-
dium compared to saline control. By use of a cardiac catheter in close-chest preparation,
heart from vigilant hHO-1 plasmids treated mice showed improved recovery of contractile
and diastolic performance after MI compared with saline control.
Conclusions: This study documents the beneficial regulation and therapeutic effect of
vigilant plasmid-mediated hHO-1 gene transfer. This novel prophylaxis gene transfer
strategy can provide cardiac specific protection from future repeated bouts of ischemic
injury.
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406-4 Mice Lacking the Transcription Factor CHF1/Hey2 Show 
Decreased Arterial Neointimal Formation After Injury 
and Impaired Vascular Smooth Muscle Cell 
Responsiveness to Growth Factors
Yasuhiko Sakata, Fan Xiang, Zhiping Chen, Yoriko Kiriyama, Caramai N. Kamei, Daniel I. 
Simon, Michael T. Chin, Brigham & Women's Hospital, Cambridge, MA
Background: The hairy-related bHLH transcription factor, CHF1/Hey2, has been shown
to play an important role in zebrafish vascular development, however, no anatomical
defects in the vascular system have been reported in CHF1/Hey2-deficient mice. Meth-
ods: We investigated the functional vascular phenotype of CHF1/Hey2-deficient mice by
measuring vascular remodeling after injury in vivo and primary cultured vascular smooth
muscle cell (VSMC) function in vitro. Results: Neointima formation after arterial wire
injury was markedly decreased in KO compared to WT mice (0.025+0.011 mm2 in WT
(n=13) vs. 0.016+0.008 mm2 in KO (n=12), p<0.05). Analysis of primary cultured VSMCs
revealed that CHF1/Hey2 deficient VSMCs proliferate comparably to WT VSMCs but
showed decreased migration in response to platelet derived growth factor (PDGF)
(62.6+10.3/CPF vs. 37.2+13.5/CPF, p<0.01) and heparin-binding epidermal growth fac-
tor-like growth factor (HB-EGF)(27.4+7.7/CPF vs. 6.4+3.7/CPF, p<0.05) as assessed by
modified Boyden chamber assay. Further, PDGF and HB-EGF induced diminished
